| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.1 | 0.7 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |